Reagents for the treatment of oculopharyngeal muscular dystrophy (OPMD) and their use

摘要

The present disclosure relates to RNA interference (RNAi) reagents for treatment of oculopharyngeal muscular dystrophy (OPMD), compositions comprising same, and use thereof to treat individuals suffering from OPMD or which are predisposed thereto.